Laurion Capital Management LP Teva Pharmaceutical Industries LTD Transaction History

Laurion Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $1 Million - $1.29 Million	-116,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $1.31 Million - $1.94 Million	-152,500 Reduced 56.67%	116,600 $1.05 Million
Q3 2019 Nov 13, 2019	BUY	$6.16 - $9.6 $999,768 - $1.56 Million	162,300 Added 151.97%	269,100 $1.85 Million
Q2 2019 Aug 13, 2019	BUY	$8.12 - $15.72 $867,215 - $1.68 Million	106,800 New	106,800 $986,000
Q1 2019 May 08, 2019	SELL	$15.58 - $20.01 $199,704 - $256,488	-12,818 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $156,113 - $255,088	10,700 Added 505.19%	12,818 $198,000
Q3 2018 Nov 13, 2018	SELL	$21.06 - $25.65 $106,353 - $129,532	-5,050 Reduced 70.45%	2,118 $46,000
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $134,998 - $198,915	-8,050 Reduced 52.9%	7,168 $174,000
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $2.79 Million - $3.69 Million	-167,000 Reduced 91.65%	15,218 $260,000
Q4 2017 Feb 13, 2018	BUY	$11.23 - $19.1 $214,818 - $365,363	19,129 Added 11.73%	182,218 $3.45 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $2.51 Million - $5.25 Million	163,089	163,089 $2.87 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.